18P A translational project of the WSG-ADAPT-TN trial demonstrates immunomodulatory and anti-viral defense gene networks predicting pathological complete response (pCR) and survival after de-escalated neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC)
In: ESMO Open, Jg. 8 (2023), Heft 1, S. 101242
academicJournal
Zugriff:
Titel: |
18P A translational project of the WSG-ADAPT-TN trial demonstrates immunomodulatory and anti-viral defense gene networks predicting pathological complete response (pCR) and survival after de-escalated neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC)
|
---|---|
Autor/in / Beteiligte Person: | Graeser, M. ; Harbeck, N. ; Gluz, O. ; Nitz, U.A. ; Christgen, M. ; Kuemmel, S. ; Grischke, E M. ; Forstbauer, H. ; Braun, M. ; Warm, M. ; Hackmann, J.C. ; Uleer, C. ; Aktas, B. ; Würstlein, R. ; Pelz, E. ; Eulenburg, C. Zu ; Kreipe, H. ; Trau, M. ; Stirzaker, C. ; Korbie, D. |
Link: | |
Zeitschrift: | ESMO Open, Jg. 8 (2023), Heft 1, S. 101242 |
Veröffentlichung: | Elsevier BV, 2023 |
Medientyp: | academicJournal |
ISSN: | 2059-7029 |
DOI: | 10.1016/j.esmoop.2023.101242 |
Schlagwort: |
|
Sonstiges: |
|